Skip to main content

Closed

HOWL: Werewolf Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

4thpctl

Volume

3.90×avg

Market Cap

17.16MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Werewolf Therapeutics, Inc.

HOWLNASDAQ Global Select·USD·Closed

Werewolf Therapeutics, Inc.

HOWLNASDAQ·USD·Closed

$0.35

−29.44%

$0.35

−$0.15 (29.44%)

52W Range

4thpctl

Volume

3.90×avg

Mkt Cap

17.16MUSD

P/E

-0.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings